Literature DB >> 16026864

Ca2+, mitochondria and selective motoneuron vulnerability: implications for ALS.

Friederike von Lewinski1, Bernhard U Keller.   

Abstract

Motoneurons are selectively damaged in amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disorder. Although the underlying mechanisms are not completely understood, increasing evidence indicates that motoneurons are particularly sensitive to disruption of mitochondria and Ca(2+)-dependent signalling cascades. Comparison of ALS-vulnerable and ALS-resistant neurons identified low Ca(2+)-buffering capacity and a strong impact of mitochondrial signal cascades as important risk factors. Under physiological conditions, weak Ca(2+) buffers are valuable because they facilitate rapid relaxation times of Ca(2+) transients in motoneurons during high-frequency rhythmic activity. However, under pathological conditions, weak Ca(2+) buffers are potentially dangerous because they accelerate a vicious circle of mitochondrial disruption, Ca(2+) disregulation and excitotoxic cell damage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16026864     DOI: 10.1016/j.tins.2005.07.001

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  58 in total

1.  Functional up-regulation of the M-current by retigabine contrasts hyperexcitability and excitotoxicity on rat hypoglossal motoneurons.

Authors:  Filippo Ghezzi; Laura Monni; Andrea Nistri
Journal:  J Physiol       Date:  2018-05-30       Impact factor: 5.182

2.  An in vitro protocol for recording from spinal motoneurons of adult rats.

Authors:  Jonathan S Carp; Ann M Tennissen; Donna L Mongeluzi; Christopher J Dudek; Xiang Yang Chen; Jonathan R Wolpaw
Journal:  J Neurophysiol       Date:  2008-05-07       Impact factor: 2.714

3.  Optimized methods for rapidly dissecting spinal cords and harvesting spinal motor neurons with high survival and purity from rats at different embryonic stages.

Authors:  Shudong Chen; Ruimin Tian; Hui Li; Meihui Chen; Hu Zhang; Dingkun Lin
Journal:  J Spinal Cord Med       Date:  2017-05-25       Impact factor: 1.985

4.  Circuit-Specific Early Impairment of Proprioceptive Sensory Neurons in the SOD1G93A Mouse Model for ALS.

Authors:  Soju Seki; Toru Yamamoto; Kiara Quinn; Igor Spigelman; Antonios Pantazis; Riccardo Olcese; Martina Wiedau-Pazos; Scott H Chandler; Sharmila Venugopal
Journal:  J Neurosci       Date:  2019-09-17       Impact factor: 6.167

5.  Altered postnatal maturation of electrical properties in spinal motoneurons in a mouse model of amyotrophic lateral sclerosis.

Authors:  K A Quinlan; J E Schuster; R Fu; T Siddique; C J Heckman
Journal:  J Physiol       Date:  2011-02-28       Impact factor: 5.182

6.  Adult spinal motoneurones are not hyperexcitable in a mouse model of inherited amyotrophic lateral sclerosis.

Authors:  Nicolas Delestrée; Marin Manuel; Caroline Iglesias; Sherif M Elbasiouny; C J Heckman; Daniel Zytnicki
Journal:  J Physiol       Date:  2014-01-20       Impact factor: 5.182

7.  Mutant SOD1-expressing astrocytes release toxic factors that trigger motoneuron death by inducing hyperexcitability.

Authors:  Elsa Fritz; Pamela Izaurieta; Alexandra Weiss; Franco R Mir; Patricio Rojas; David Gonzalez; Fabiola Rojas; Robert H Brown; Rodolfo Madrid; Brigitte van Zundert
Journal:  J Neurophysiol       Date:  2013-03-13       Impact factor: 2.714

8.  Motoneuron Death after Human Spinal Cord Injury.

Authors:  Robert M Grumbles; Christine K Thomas
Journal:  J Neurotrauma       Date:  2016-08-25       Impact factor: 5.269

Review 9.  Mitochondria in neuroplasticity and neurological disorders.

Authors:  Mark P Mattson; Marc Gleichmann; Aiwu Cheng
Journal:  Neuron       Date:  2008-12-10       Impact factor: 17.173

10.  Impairment of mitochondrial calcium handling in a mtSOD1 cell culture model of motoneuron disease.

Authors:  Manoj Kumar Jaiswal; Wolf-Dieter Zech; Miriam Goos; Christine Leutbecher; Alberto Ferri; Annette Zippelius; Maria Teresa Carrì; Roland Nau; Bernhard U Keller
Journal:  BMC Neurosci       Date:  2009-06-22       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.